Solicitation of Nominations for Membership on the National Vaccine Advisory Committee, 23977-23979 [2014-09634]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
23977
[FR Doc. 2014–09643 Filed 4–28–14; 8:45 am]
thereby engage in operating a savings
association, pursuant to section
225.28(b)(4)(ii).
Comments regarding this application
must be received not later than May 27,
2014.
Board of Governors of the Federal Reserve
System, April 24, 2014.
Michael J. Lewandowski,
Associate Secretary of the Board.
Board of Governors of the Federal Reserve
System, April 24, 2014.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2014–09705 Filed 4–28–14; 8:45 am]
BILLING CODE 6210–01–P
Dated: April 23, 2014.
Sarah Whittle Spooner,
Executive Director.
Peoples Finance Company, both in
Cameron, Texas, and thereby engage in
extending credit and servicing loans,
pursuant to section 225.28(b)(1).
Comments on this application must
be received by May 8, 2014.
[FR Doc. 2014–09704 Filed 4–28–14; 8:45 am]
following link: https://www.flra.gov/
webfm_send/866.
FOR FURTHER INFORMATION CONTACT:
Questions regarding the service contract
inventory should be directed to Xavier
Storr, Director, Administrative Services
Division, Federal Labor Relations
Authority, at (202) 218–7764.
BILLING CODE 6210–01–P
BILLING CODE 6727–01–P
FEDERAL RESERVE SYSTEM
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies;
Correction
This notice corrects a notice (FR Doc.
2014–09225) published on page 22682
of the issue for Wednesday, April 23,
2014.
Under the Federal Reserve Bank of
Dallas heading, the entry for Central
Texas Financial Corp., Cameron, Texas,
is revised to read as follows:
sroberts on DSK5SPTVN1PROD with NOTICES
Notice of Proposals To Engage in or To
Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Central Texas Financial Corp.,
Cameron, Texas; to acquire 100 percent
of the voting shares of Citcamco
Incorporated, and indirectly acquire
VerDate Mar<15>2010
16:56 Apr 28, 2014
Jkt 232001
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than May 14, 2014.
A. Federal Reserve Bank of Boston
(Richard Walker, Community Affairs
Officer) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204:
1. Meridian Bancorp, Inc., Peabody,
Massachusetts; to engage de novo in
extending credit and servicing loans,
pursuant to section 225.28(b)(1).
B. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Chemical Financial Corporation,
Midland, Michigan; to acquire 100
percent of the voting shares of
Northwestern Bancorp, Inc., and
indirectly acquire Northwestern Bank,
both in Traverse City, Michigan, and
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the National Vaccine
Advisory Committee
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
Authority: 42 U.S.C. 300aa-5, Section 2105
of the Public Health Service (PHS) Act, as
amended. The National Vaccine Advisory
Committee is governed by the provisions of
Public Law 92–463, as amended (5 U.S.C.
Appendix 2), which sets forth standards for
the formation and use of advisory
committees.
The National Vaccine
Program Office (NVPO), a program
office within the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS), is
soliciting nominations of qualified
candidates to be considered for
appointment as public members to the
National Vaccine Advisory Committee
(NVAC). The activities of this
Committee are governed by the Federal
Advisory Committee Act (FACA).
Management and support of the NVAC
and its activities are the responsibility
of the NVPO.
The NVAC serves an advisory role,
providing peer review, consultation,
advice, and recommendations to the
Assistant Secretary for Health in his
capacity as the Director of the National
Vaccine Program, on matters related to
the Program’s responsibilities.
Specifically, the Committee studies and
recommends ways to encourage the
availability of an adequate supply of
safe and effective vaccination products
in the United States; recommends
research priorities and other measures
to enhance the safety and efficacy of
vaccines. The Committee also advises
the Assistant Secretary for Health in the
implementation of Sections 2102 and
SUMMARY:
E:\FR\FM\29APN1.SGM
29APN1
sroberts on DSK5SPTVN1PROD with NOTICES
23978
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
2103 of the PHS Act; and identifies
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: All nominations for membership
on the Committee must be received no
later than 5:00 p.m. EDT on May 29,
2014, to the address listed below.
ADDRESSES: All nominations should be
mailed or delivered to: Bruce Gellin,
M.D., M.P.H., Executive Secretary,
NVAC, Office of the Assistant Secretary
for Health, Department of Health and
Human Services, 200 Independence
Avenue SW., Room 715–H, Washington,
DC 20201.
FOR FURTHER INFORMATION CONTACT:
Jennifer Gordon, Ph.D., Public Health
Analyst, National Vaccine Program
Office, Department of Health and
Human Services, 200 Independence
Avenue SW., Room 733G, Washington,
DC 20201; (202) 260–6619;
Jennifer.Gordon@hhs.gov.
A copy of the Committee charter
which includes the NVAC’s structure
and functions as well as a list of the
current membership can be obtained by
contacting Dr. Gordon or by accessing
the NVAC Web site at: www.hhs.gov/
nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications,
and Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
NVAC. Committee members provide
peer review, consultation, advice, and
recommendations to the Assistant
Secretary for Health, in his capacity as
the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Individuals
selected for appointment to the NVAC
will serve as voting members. The
NVAC consists of 17 voting members:
15 public members, including the Chair,
and two representative members.
Individuals selected for appointment to
the NVAC can be invited to serve terms
of up to four years. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of NVAC’s objectives.
Interested candidates should
demonstrate a willingness to commit
time to NVAC activities and the ability
to work constructively and effectively
on committees.
Public Members: Public members are
individuals who are appointed to the
NVAC to exercise their own
independent, best judgment on behalf of
VerDate Mar<15>2010
16:56 Apr 28, 2014
Jkt 232001
the government. It is expected that
public members will discuss and
deliberate in a manner that is free from
conflicts of interest. Public members to
the NVAC shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of state
or local health agencies, or public health
organizations.
Representative Members:
Representative members are individuals
who are appointed to the NVAC to
provide the views of industry or a
special interest group. While they may
be experts in various topic areas
discussed by the Committee, they
should not present their own
viewpoints, but rather those of the
industry or special interest group they
represent. NVAC representative
members shall serve specifically to
represent the viewpoints or perspectives
of the vaccine manufacturing industry
or groups engaged in vaccine research or
the manufacture of vaccines.
This announcement is to solicit
nominations of qualified candidates to
fill positions in the public member
category of the NVAC that are currently
vacant or are scheduled to be vacated
during the 2015 calendar year.
Travel reimbursement and
compensation for services provided to
the Committee: All NVAC members are
authorized to receive the prescribed per
diem allowance and reimbursement for
travel expenses that are incurred to
attend meetings and conduct authorized
NVAC-related business, in accordance
with standard government travel
regulations. Members appointed to the
NVAC as public members (see
definition above) also are authorized to
receive a stipend for services provided
at public meetings of the Committee. All
other services that are performed by the
public members outside the Committee
meetings shall be provided without
compensation. Representative members
(see definition above) will serve without
compensation.
Expertise sought for the NVAC: In
accordance with the charter, persons
nominated for appointment as members
of the NVAC should be among
authorities knowledgeable in areas
related to vaccine safety, vaccine
effectiveness, and vaccine supply. In
order to enhance the diversity of
expertise included in Committee
discussions, NVPO is seeking
nominations of individuals to serve on
the NVAC as public members in the
following disciplines/topic areas:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
• vaccine research and development,
vaccine clinical trials, and vaccine
regulatory science;
• vaccine safety and post-marketing
surveillance;
• vaccine access and financing;
• health information technologies and
immunization information systems;
• immunization program
implementation and management;
• vaccine communications;
• bioethicists with knowledge of
vaccine-related issues
How to submit nominations:
Nominations should be typewritten. The
following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity); and a statement
that the nominee is willing to serve as
a member of the Committee (2) the
nominator’s name, address and daytime
telephone number, home and/or work
address, telephone number, and email
address; and (3) a copy of the nominee’s
current curriculum vitae.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
Applications cannot be submitted by
facsimile. The names of federal
employees should not be nominated for
consideration of appointment to this
Committee.
The Department makes every effort to
ensure that the membership of HHS
federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made to ensure
that a broad representation of
geographic areas, gender, ethnic and
minority groups, and the disabled are
given consideration for membership on
HHS federal advisory committees.
Appointment to this Committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
The Standards of Ethical Conduct for
Employees of the Executive Branch
(www.oge.gov/Laws-and-Regulations/
Employee-Standards-of-Conduct/
Employee-Standards-of-Conduct) are
applicable to individuals who are
E:\FR\FM\29APN1.SGM
29APN1
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
appointed as public members of federal
advisory committees. Individuals
appointed to serve as public members of
federal advisory committees are
classified as special government
employees (SGEs). SGEs are government
employees for purposes of the conflict
of interest laws. Therefore, individuals
appointed to serve as public members of
NVAC are subject to an ethics review.
The ethics review is conducted to
determine if the individual has any
interests and/or activities in the private
sector that may conflict with
performance of their official duties as a
member of the NVAC. Individuals
appointed to serve as public members of
the NVAC will be required to disclose
information regarding financial
holdings, consultancies, research grants
and/or contracts, and the absence of an
appearance of a loss of impartiality.
Dated: April 22, 2014.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2014–09634 Filed 4–28–14; 8:45 am]
BILLING CODE 4150–44–P
sroberts on DSK5SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Evaluating Promising
Strategies to Build the Evidence Base for
Sexual Violence Prevention, Funding
Opportunity Announcement (FOA)
CE14–005, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:30 a.m.–7:30 p.m.
EDT, May 15, 2014 (Closed)
Place: CDC, 4770 Buford Highway,
Conference Room 8C, Atlanta, Georgia
30341
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
16:56 Apr 28, 2014
[FR Doc. 2014–09703 Filed 4–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Centers for Disease Control and
Prevention
Jkt 232001
Review Officer, CDC, 4770 Buford
Highway, NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
0641.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–09701 Filed 4–28–14; 8:45 am]
BILLING CODE 4163–18–P
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
applications received in response to
‘‘Evaluating Promising Strategies to
Build the Evidence Base for Sexual
Violence Prevention, FOA CE14–005.’’
Contact Person For More Information:
Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
0641.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
23979
The meeting announced below
concerns Research Grants for Preventing
Violence and Violence Related Injury,
Funding Opportunity Announcement
(FOA) CE14–006, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:30 a.m.–5:30 p.m.
EDT, May 29–30, 2014 (Closed)
Place: CDC, 4770 Buford Highway,
Conference Rooms 8C and 8A, Atlanta,
Georgia 30341
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research Grants for Preventing
Violence and Violence Related Injury,
FOA CE14–006.’’
Contact Person For More Information:
Donald Blackman, Ph.D., Scientific
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 9:15 a.m.–4:15 p.m.,
May 22, 2014; 8:30 a.m.–12:30 p.m.,
May 23, 2014.
Place: CDC, 4770 Buford Highway,
Atlanta, Georgia 30341.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 60
people.
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and well being; and
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Notices]
[Pages 23977-23979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09634]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the National
Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health
Service (PHS) Act, as amended. The National Vaccine Advisory
Committee is governed by the provisions of Public Law 92-463, as
amended (5 U.S.C. Appendix 2), which sets forth standards for the
formation and use of advisory committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of the Assistant Secretary for Health, Department of
Health and Human Services (HHS), is soliciting nominations of qualified
candidates to be considered for appointment as public members to the
National Vaccine Advisory Committee (NVAC). The activities of this
Committee are governed by the Federal Advisory Committee Act (FACA).
Management and support of the NVAC and its activities are the
responsibility of the NVPO.
The NVAC serves an advisory role, providing peer review,
consultation, advice, and recommendations to the Assistant Secretary
for Health in his capacity as the Director of the National Vaccine
Program, on matters related to the Program's responsibilities.
Specifically, the Committee studies and recommends ways to encourage
the availability of an adequate supply of safe and effective
vaccination products in the United States; recommends research
priorities and other measures to enhance the safety and efficacy of
vaccines. The Committee also advises the Assistant Secretary for Health
in the implementation of Sections 2102 and
[[Page 23978]]
2103 of the PHS Act; and identifies annually the most important areas
of government and non-government cooperation that should be considered
in implementing Sections 2102 and 2103 of the PHS Act.
DATES: All nominations for membership on the Committee must be received
no later than 5:00 p.m. EDT on May 29, 2014, to the address listed
below.
ADDRESSES: All nominations should be mailed or delivered to: Bruce
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the
Assistant Secretary for Health, Department of Health and Human
Services, 200 Independence Avenue SW., Room 715-H, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Jennifer Gordon, Ph.D., Public Health
Analyst, National Vaccine Program Office, Department of Health and
Human Services, 200 Independence Avenue SW., Room 733G, Washington, DC
20201; (202) 260-6619; Jennifer.Gordon@hhs.gov.
A copy of the Committee charter which includes the NVAC's structure
and functions as well as a list of the current membership can be
obtained by contacting Dr. Gordon or by accessing the NVAC Web site at:
www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications, and Information Required: As
part of an ongoing effort to enhance deliberations and discussions with
the public on vaccine and immunization policy, nominations are being
sought for interested individuals to serve on the NVAC. Committee
members provide peer review, consultation, advice, and recommendations
to the Assistant Secretary for Health, in his capacity as the Director
of the National Vaccine Program, on matters related to the Program's
responsibilities. Individuals selected for appointment to the NVAC will
serve as voting members. The NVAC consists of 17 voting members: 15
public members, including the Chair, and two representative members.
Individuals selected for appointment to the NVAC can be invited to
serve terms of up to four years. Selection of members is based on
candidates' qualifications to contribute to the accomplishment of
NVAC's objectives. Interested candidates should demonstrate a
willingness to commit time to NVAC activities and the ability to work
constructively and effectively on committees.
Public Members: Public members are individuals who are appointed to
the NVAC to exercise their own independent, best judgment on behalf of
the government. It is expected that public members will discuss and
deliberate in a manner that is free from conflicts of interest. Public
members to the NVAC shall be selected from individuals who are engaged
in vaccine research or the manufacture of vaccines, or who are
physicians, members of parent organizations concerned with
immunizations, representatives of state or local health agencies, or
public health organizations.
Representative Members: Representative members are individuals who
are appointed to the NVAC to provide the views of industry or a special
interest group. While they may be experts in various topic areas
discussed by the Committee, they should not present their own
viewpoints, but rather those of the industry or special interest group
they represent. NVAC representative members shall serve specifically to
represent the viewpoints or perspectives of the vaccine manufacturing
industry or groups engaged in vaccine research or the manufacture of
vaccines.
This announcement is to solicit nominations of qualified candidates
to fill positions in the public member category of the NVAC that are
currently vacant or are scheduled to be vacated during the 2015
calendar year.
Travel reimbursement and compensation for services provided to the
Committee: All NVAC members are authorized to receive the prescribed
per diem allowance and reimbursement for travel expenses that are
incurred to attend meetings and conduct authorized NVAC-related
business, in accordance with standard government travel regulations.
Members appointed to the NVAC as public members (see definition above)
also are authorized to receive a stipend for services provided at
public meetings of the Committee. All other services that are performed
by the public members outside the Committee meetings shall be provided
without compensation. Representative members (see definition above)
will serve without compensation.
Expertise sought for the NVAC: In accordance with the charter,
persons nominated for appointment as members of the NVAC should be
among authorities knowledgeable in areas related to vaccine safety,
vaccine effectiveness, and vaccine supply. In order to enhance the
diversity of expertise included in Committee discussions, NVPO is
seeking nominations of individuals to serve on the NVAC as public
members in the following disciplines/topic areas:
vaccine research and development, vaccine clinical trials,
and vaccine regulatory science;
vaccine safety and post-marketing surveillance;
vaccine access and financing;
health information technologies and immunization
information systems;
immunization program implementation and management;
vaccine communications;
bioethicists with knowledge of vaccine-related issues
How to submit nominations: Nominations should be typewritten. The
following information should be included in the package of material
submitted for each individual being nominated for consideration: (1) A
letter of nomination that clearly states the name and affiliation of
the nominee, the basis for the nomination (i.e., specific attributes
which qualify the nominee for service in this capacity); and a
statement that the nominee is willing to serve as a member of the
Committee (2) the nominator's name, address and daytime telephone
number, home and/or work address, telephone number, and email address;
and (3) a copy of the nominee's current curriculum vitae.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information. Incomplete nominations will not be processed for
consideration. The letter from the nominator and certification of the
nominated individual must bear original signatures; reproduced copies
of these signatures are not acceptable. Applications cannot be
submitted by facsimile. The names of federal employees should not be
nominated for consideration of appointment to this Committee.
The Department makes every effort to ensure that the membership of
HHS federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
to ensure that a broad representation of geographic areas, gender,
ethnic and minority groups, and the disabled are given consideration
for membership on HHS federal advisory committees. Appointment to this
Committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Standards of Ethical Conduct for Employees of the Executive
Branch (www.oge.gov/Laws-and-Regulations/Employee-Standards-of-Conduct/Employee-Standards-of-Conduct) are applicable to individuals who are
[[Page 23979]]
appointed as public members of federal advisory committees. Individuals
appointed to serve as public members of federal advisory committees are
classified as special government employees (SGEs). SGEs are government
employees for purposes of the conflict of interest laws. Therefore,
individuals appointed to serve as public members of NVAC are subject to
an ethics review. The ethics review is conducted to determine if the
individual has any interests and/or activities in the private sector
that may conflict with performance of their official duties as a member
of the NVAC. Individuals appointed to serve as public members of the
NVAC will be required to disclose information regarding financial
holdings, consultancies, research grants and/or contracts, and the
absence of an appearance of a loss of impartiality.
Dated: April 22, 2014.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine
Program Office, Executive Secretary, National Vaccine Advisory
Committee.
[FR Doc. 2014-09634 Filed 4-28-14; 8:45 am]
BILLING CODE 4150-44-P
